Nasdaq:US$20.09 (-0.08) | HKEX:HK$31.40 (-0.65) | AIM:£3.24 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 23 Dec 2014

Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1,2,3 tyrosine kinases for cancer therapy (Cancer Biology & Therapy 2014)